1
项与 Autologous cultured urological tissue cells (inRegen) 相关的临床试验A Phase 1, Open-Label Safety and Delivery Optimization Study of an Autologous Neo-Kidney Augment (NKA) in Patients With Chronic Kidney Disease (CKD)
The primary purpose of this study is to assess the safety and optimal delivery of the Neo-Kidney Augment (NKA) when implanted at one site in a recipient kidney. NKA is made from expanded autologous, homologous, selected renal cells (SRC) obtained from the patient's kidney biopsy.
100 项与 Autologous cultured urological tissue cells (inRegen) 相关的临床结果
100 项与 Autologous cultured urological tissue cells (inRegen) 相关的转化医学
100 项与 Autologous cultured urological tissue cells (inRegen) 相关的专利(医药)
100 项与 Autologous cultured urological tissue cells (inRegen) 相关的药物交易